Prodelphinidin B4

CAS : 68964-95-4

Ref. 3D-TCA96495

Informations sur le produit

• Nom: Prodelphinidin B4
• Synonymes: (2R,2′R,3S,3′R,4S)-3,3′,4,4′-Tetrahydro-2,2′-bis(3,4,5-trihydroxyphenyl)[4,8′-bi-2H-1-benzopyran]-3,3′,5,5′,7,7′-hexol, Prodelphinidin B₄, [4,8'-bi-2H-1-benzopyran]-3,3',5,5',7,7'-hexol, 3,3',4,4'-tetrahydro-2,2'-bis(3,4,5-trihydroxyphenyl)-, (2R,2'R,3S,3'R,4S)-, [4,8′-Bi-2H-1-benzopyran]-3,3′,5,5′,7,7′-hexol, 3,3′,4,4′-tetrahydro-2,2′-bis(3,4,5-trihydroxyphenyl)-, (2R,2′R,3S,3′R,4S)-, [4,8′-Bi-2H-1-benzopyran]-3,3′,5,5′,7,7′-hexol, 3,3′,4,4′-tetrahydro-2,2′-bis(3,4,5-trihydroxyphenyl)-, [2R-[2α,3β,4α(2′R*,3′R*)]]-

Description

Prodelphinidin B4 is a natural compound that has shown potential as a medicinal cycle inhibitor in the treatment of cancer. It has been found to induce apoptosis, or programmed cell death, in human leukemia and cancer cells. Prodelphinidin B4 inhibits the activity of protein kinases, which are enzymes that regulate cellular processes such as cell growth and division. This inhibition leads to the suppression of tumor growth and may be useful in developing new anticancer drugs. Prodelphinidin B4 can be detected in urine samples and has been used in Chinese traditional medicine for its anti-tumor properties. Its effectiveness as a cancer treatment makes it a promising candidate for further research and development of kinase inhibitors.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 610.5 g/mol
• Formule: C₃₀H₂₆O₁₄
• Degré de pureté: Min. 95%